Management of Psychosis in Parkinson’s Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition

Table 4

Clinical and demographic features of PD patients with and PD patients without hallucinations after following up prospectively.

	PD-mH ()	PD-NH; ()
Age, y			0.06 (t-test)
Education, y			0.45 (t-test)
Sex, ♂			0.91 ()
Disease duration, months from onset of motor symptoms			0.12 (t-test)
UPDRS-III, at baseline			0.47 (t-test)
Hoehn & Yahr, at baseline			0.19 (t-test)
Predominance of motor symptoms, right%	52.3	65.5	0.23 ()
Depression, %	52.3	41.40%	0.39 ()
Anxiety, %	47.6	48.2	0.91 ()
Apathy, %	42.8	55.1	0.47 ()
Insomnia, %	38.1	41.3	0.68 ()
Daytime sleepiness, %	38.1	27.5	0.45 ()
RBD, %	38.1	10.3	0.03 ()
Hyposmia, %	33.3	27.5	0.80 ()

PD-mH: Parkinson’s disease with minor hallucinations; PD-NH: PD without hallucinations; UPDRS-III: Unified PD Rating Scale, motor section; RBD: REM sleep behaviour disorder; reference: Pagonabarraga et al., 2016 [72].